The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Peptide Therapeutics-Global Market Insights and Sales Trends 2025

Peptide Therapeutics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1824000

No of Pages : 101

Ask Your Query

Synopsis

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

The global Peptide Therapeutics market size is expected to reach US$ 63600 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Peptide Therapeutics in various end use industries.

The expanding demands from the Cancer, Metabolic Disorders, Central Nervous System and Other, are propelling Peptide Therapeutics market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.

Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Peptide Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Peptide Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Peptide Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Peptide Therapeutics covered in this report include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie and Ipsen, etc.

The global Peptide Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • AbbVie
  • Ipsen
  • Ferring
  • Merck
  • The Medicines
  • J & J

Global Peptide Therapeutics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Peptide Therapeutics market, Segment by Type:

  • Injection
  • Oral
  • Other

Global Peptide Therapeutics market, by Application

  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Peptide Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Peptide Therapeutics
1.1 Peptide Therapeutics Market Overview
1.1.1 Peptide Therapeutics Product Scope
1.1.2 Peptide Therapeutics Market Status and Outlook
1.2 Global Peptide Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Peptide Therapeutics Market Size by Region (2018-2029)
1.4 Global Peptide Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Peptide Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Peptide Therapeutics Market Size (2018-2029)
1.6.1 North America Peptide Therapeutics Market Size (2018-2029)
1.6.2 Europe Peptide Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Peptide Therapeutics Market Size (2018-2029)
1.6.4 Latin America Peptide Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Peptide Therapeutics Market Size (2018-2029)
2 Peptide Therapeutics Market by Type
2.1 Introduction
2.1.1 Injection
2.1.2 Oral
2.1.3 Other
2.2 Global Peptide Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Peptide Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Peptide Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Peptide Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Peptide Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Peptide Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Peptide Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Peptide Therapeutics Revenue Breakdown by Type (2018-2029)
3 Peptide Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Metabolic Disorders
3.1.3 Central Nervous System
3.1.4 Other
3.2 Global Peptide Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Peptide Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Peptide Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Peptide Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Peptide Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Peptide Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Peptide Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Peptide Therapeutics Revenue Breakdown by Application (2018-2029)
4 Peptide Therapeutics Competition Analysis by Players
4.1 Global Peptide Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2022)
4.3 Date of Key Players Enter into Peptide Therapeutics Market
4.4 Global Top Players Peptide Therapeutics Headquarters and Area Served
4.5 Key Players Peptide Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Peptide Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Peptide Therapeutics Products, Services and Solutions
5.1.4 Sanofi Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Teva
5.2.1 Teva Profile
5.2.2 Teva Main Business
5.2.3 Teva Peptide Therapeutics Products, Services and Solutions
5.2.4 Teva Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Profile
5.3.2 Novo Nordisk Main Business
5.3.3 Novo Nordisk Peptide Therapeutics Products, Services and Solutions
5.3.4 Novo Nordisk Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Peptide Therapeutics Products, Services and Solutions
5.4.4 Takeda Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Peptide Therapeutics Products, Services and Solutions
5.5.4 Eli Lilly Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Peptide Therapeutics Products, Services and Solutions
5.6.4 AstraZeneca Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Peptide Therapeutics Products, Services and Solutions
5.7.4 Novartis Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Peptide Therapeutics Products, Services and Solutions
5.8.4 AbbVie Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 AbbVie Recent Developments
5.9 Ipsen
5.9.1 Ipsen Profile
5.9.2 Ipsen Main Business
5.9.3 Ipsen Peptide Therapeutics Products, Services and Solutions
5.9.4 Ipsen Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Ipsen Recent Developments
5.10 Ferring
5.10.1 Ferring Profile
5.10.2 Ferring Main Business
5.10.3 Ferring Peptide Therapeutics Products, Services and Solutions
5.10.4 Ferring Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Ferring Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Peptide Therapeutics Products, Services and Solutions
5.11.4 Merck Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Merck Recent Developments
5.12 The Medicines
5.12.1 The Medicines Profile
5.12.2 The Medicines Main Business
5.12.3 The Medicines Peptide Therapeutics Products, Services and Solutions
5.12.4 The Medicines Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 The Medicines Recent Developments
5.13 J & J
5.13.1 J & J Profile
5.13.2 J & J Main Business
5.13.3 J & J Peptide Therapeutics Products, Services and Solutions
5.13.4 J & J Peptide Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 J & J Recent Developments
6 North America
6.1 North America Peptide Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Peptide Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Peptide Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Peptide Therapeutics Market Dynamics
11.1 Peptide Therapeutics Industry Trends
11.2 Peptide Therapeutics Market Drivers
11.3 Peptide Therapeutics Market Challenges
11.4 Peptide Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock